Your Health, We Care

Home >Drug List>Neratinib
  • Neratinib
  • Neratinib

Neratinib(LuciNera)

Another NameNerlynx, 奈拉替尼, 来那替尼, 贺俪安

IndicationsIt is indicated for the treatment of early-stage and advanced-stage HER2-positive breast cancer, and can be used as a monotherapy for adjuvant treatment or in combination with capecitabine for metasta

Specs

  • 40mg*180Tabs
  • Reg No.10 L 1225/24
  • Inspection NO.2563-24
  • Dosage FormTablets
  • Indate24 months
  • Get in touch for a free consultation
  • WhatsApp

    Telegram name: Vira

  • Name: LUCIUS

    No.:0085253923643

Warm tips:Please purchase and use the medication under pharmacist guidance as the outer packaging is for reference only and the information is intended for professionals.
Introduction of Neratinib

This drug manufactured by Lucius Pharmaceuticals is a targeted therapy for HER2-positive breast cancer, with definite clinical efficacy, a standardized adverse reaction management plan, and favorable therapeutic cost-effectiveness.

Medicine-related columns

Instructions of Neratinib

Lucius Related Certificates

109-Neratinib Test Report_proc.jpg

Drug Test Report

10L1225_24 Neratinib Approval_proc.jpg

Drug Approval Certificate

Overview of Key Information for Neratinib.

Active Ingredient

The active ingredient is neratinib, with 40 mg per tablet.

Indicated Population

For adult patients with HER2-positive breast cancer.

Dosage and Administration

The recommended dosage is 240 mg (6 tablets) once daily, to be taken with meals. The specific treatment course shall be determined according to the patient’s condition.

Use in Special Populations

Dosage adjustment is required for patients with severe hepatic impairment. This drug is contraindicated in pregnant women and lactating women.

Overdosage

There is no specific antidote for overdosage. Symptomatic and supportive treatments should be administered.

Storage Conditions

Store the medicine at room temperature and protect it from moisture.

Pharmacokinetics

Pharmacokinetic data indicate that its half-life is approximately 14.6 hours, and it is mainly metabolized in the liver.

FDA,2021.06